The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: Goldman Sachs Raises Pearson And Informa

Tue, 17th Mar 2020 09:23

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

----------

FTSE 100

----------

GOLDMAN SACHS RAISES PEARSON TO 'NEUTRAL' ('SELL') - PRICE TARGET 605 (505) PENCE

----------

GOLDMAN RAISES INFORMA TO 'NEUTRAL' ('SELL') - PRICE TARGET 729 (744) PENCE

----------

GOLDMAN CUTS RELX PRICE TARGET TO 2185.0 (2302.8) PENCE - 'BUY'

----------

GOLDMAN CUTS AUTO TRADER PRICE TARGET TO 653 (688) PENCE - 'BUY'

----------

GOLDMAN CUTS ITV PRICE TARGET TO 122 (147) PENCE - 'NEUTRAL'

----------

GOLDMAN CUTS WPP PRICE TARGET TO 900 (1045) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS FERGUSON PRICE TARGET TO 7100 (8100) PENCE - 'OVERWEIGHT'

----------

RBC CUTS ROYAL BANK OF SCOTLAND PRICE TARGET TO 155 (200) PENCE - 'SECTOR PERFORM'

----------

RBC CUTS LLOYDS BANKING PRICE TARGET TO 47 (66) PENCE - 'OUTPERFORM'

----------

RBC CUTS HSBC PRICE TARGET TO 440 (520) PENCE - 'UNDERPERFORM'

----------

RBC CUTS BARCLAYS PRICE TARGET TO 120 (170) PENCE - 'SECTOR PERFORM'

----------

HSBC RAISES STANDARD CHARTERED TO 'HOLD' ('REDUCE') - TARGET 480 (590) PENCE

----------

HSBC CUTS WPP PRICE TARGET TO 620 (1030) PENCE - 'HOLD'

----------

JPMORGAN CUTS DIAGEO PRICE TARGET TO 2150 (2800) PENCE - 'UNDERWEIGHT'

----------

JPMORGAN CUTS COCA-COLA HBC PRICE TARGET TO 1980 (3000) PENCE - 'OVERWEIGHT'

----------

BARCLAYS CUTS GLAXOSMITHKLINE PRICE TARGET TO 1450 (1550) PENCE - 'UNDERWEIGHT'

----------

BARCLAYS CUTS ASTRAZENECA PRICE TARGET TO 8000 (8500) PENCE - 'OVERWEIGHT'

----------

JPMORGAN CUTS RECKITT BENCKISER PRICE TARGET TO 6500 (7700) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES UNILEVER TO 'NEUTRAL' ('UNDERWEIGHT') - PRICE TARGET 3850 (4210) PENCE

----------

JPMORGAN CUTS WHITBREAD PRICE TARGET TO 2990 (3800) PENCE - 'UNDERWEIGHT'

----------

JPMORGAN CUTS INTERCONTINENTAL HOTELS TARGET TO 4150 (4600) P - 'UNDERWEIGHT'

----------

JPMORGAN CUTS COMPASS GROUP PRICE TARGET TO 1920 (2040) PENCE - 'OVERWEIGHT'

----------

JEFFERIES RAISES JUST EAT TAKEAWAY.COM TO 'BUY' ('HOLD') - PRICE TARGET 8000 PENCE

----------

FTSE 250

----------

GOLDMAN CUTS ASCENTIAL TO 'BUY' ('CONVICTION BUY') - PRICE TARGET 373 (569) PENCE

----------

KEPLER CHEUVREUX RAISES TATE & LYLE TO 'BUY' ('HOLD') - TARGET 720 PENCE

----------

LIBERUM CUTS BALFOUR BEATTY PRICE TARGET TO 320 (400) PENCE - 'BUY'

----------

LIBERUM CUTS EQUINITI PRICE TARGET TO 265 (275) PENCE - 'BUY'

----------

DEUTSCHE BANK CUTS HAMMERSON PRICE TARGET TO 200 (300) PENCE - 'BUY'

----------

HSBC CUTS 4IMPRINT GROUP PRICE TARGET TO 2215 (2820) PENCE - 'HOLD'

----------

JPMORGAN CUTS BRITVIC PRICE TARGET TO 875 (1065) PENCE - 'OVERWEIGHT'

----------

GOLDMAN CUTS HUNTING PRICE TARGET TO 160 (398) PENCE - 'SELL'

----------

GOLDMAN CUTS JOHN WOOD PRICE TARGET TO 282 (467) PENCE - 'NEUTRAL'

----------

GOLDMAN RAISES PETROFAC TO 'BUY' ('NEUTRAL') - TARGET 316 (433) PENCE

----------

JPMORGAN CUTS SSP GROUP PRICE TARGET TO 730 (790) PENCE - 'OVERWEIGHT'

----------

JEFFERIES CUTS SYNTHOMER PRICE TARGET TO 270 (375) PENCE - 'BUY'

----------

OTHER MAIN MARKET AND AIM

----------

GOLDMAN CUTS DAILY MAIL & GENERAL TRUST PRICE TARGET TO 632 (706) PENCE - 'SELL'

----------

LIBERUM CUTS KIER GROUP PRICE TARGET TO 115 (150) PENCE - 'BUY'

----------

BERENBERG CUTS BREEDON PRICE TARGET TO 105 (110) PENCE - 'BUY'

----------

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
8 Mar 2024 06:00

Astra, Sanofi's antibody 90% effective against RSV in infants - CDC

(Alliance News) - A new treatment for infant respiratory syncytial virus, RSV, – a leading cause of severe illness in US babies – is 90% effective in preventing hospitalization, health authorities said Thursday.

Read more
6 Mar 2024 14:40

UK BUDGET: Some tax cuts but vapes, tobacco and non-doms targeted

(Alliance News) - A cut to national insurance, stamp duty relief as well as a freeze on fuel and alcohol duties were among the marquee tax measures that UK Chancellor Jeremy Hunt announced in his budget on Wednesday.

Read more
5 Mar 2024 14:24

AstraZeneca's breast cancer treatment blocked for NHS use in England

(Alliance News) - A treatment that extends the life of people with advanced breast cancer has been blocked for NHS use in England in a move that potentially impacts thousands of patients.

Read more
4 Mar 2024 09:31

AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said that the European Medicines Agency has approved two marketing authorisation applications for their datopotamab deruxtecan in two types of cancer.

Read more
4 Mar 2024 07:18

AstraZeneca's chemo replacement treatment moves closer to EU approval

(Sharecast News) - European regulators have validated two marketing authorisation applications (MMAs) for AstraZeneca, as the biopharma giant's datopotamab deruxtecan chemotherapy replacement treatment comes one step closer to receiving the green light to treat two types of cancer.

Read more
26 Feb 2024 08:51

AstraZeneca's Voydeya treatment recommended for EU approval

(Alliance News) - AstraZeneca on Monday announced further support from regulators for its first-in-class blood disease treatment.

Read more
26 Feb 2024 07:22

AstraZeneca's blood-disorder drug recommended for EU approval

(Sharecast News) - European regulators has given the green light to AstraZeneca's blood-disorder drug Voydeya, the biopharma giant announced on Monday.

Read more
22 Feb 2024 17:36

EARNINGS AND TRADING: Astra closes Gracell buy, Amicorp "on track"

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and Thursday and not separately reported by Alliance News:

Read more
20 Feb 2024 10:29

AstraZeneca acquires US-based biopharmaceutical company

(Sharecast News) - Drugmaker AstraZeneca revealed late on Monday afternoon that it had successfully completed its acquisition of US-based biopharmaceutical company Icosavax.

Read more
20 Feb 2024 09:40

LONDON BROKER RATINGS: JPMorgan cuts Airtel Africa price target by 28%

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
19 Feb 2024 16:51

LONDON MARKET CLOSE: Europe lacks direction on quiet Monday

(Alliance News) - European markets lacked direction on Monday, after a quiet day as the US markets celebrated George Washington's birthday.

Read more
19 Feb 2024 15:59

London close: Stocks manage gains on globally quiet day

(Sharecast News) - London's financial markets finished in positive territory on Monday, with stocks closing in the green after overcoming minor losses earlier in the session.

Read more
19 Feb 2024 15:39

UPDATE: AstraZeneca completes USD1.1 billion acquisition of Icosavax

(Alliance News) - AstraZeneca PLC on Monday said it has completed the acquisition of Icosavax Inc.

Read more
19 Feb 2024 11:51

LONDON MARKET MIDDAY: Stocks lack direction amid quiet start to week

(Alliance News) - Stock prices in London lacked direction at midday Monday, amid a quiet start to the week.

Read more
19 Feb 2024 08:44

LONDON MARKET OPEN: Stocks drift; Currys surges on takeover interest

(Alliance News) - Stock prices in London were looking for direction early Monday, as investors weighed possible trajectories for US interest rate cuts and a China's economic recovery.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.